Vera Therapeutics announced positive long-term data from its ORIGIN Phase 2b trial of atacicept in immunoglobulin A nephropathy (IgAN), showcasing stabilized kidney function and a favorable safety profile. The results, presented at Kidney Week 2024 and published in the Journal of the American Society of Nephrology, further support the potential of atacicept as a long-term IgAN treatment and bolster confidence in the ongoing Phase 3 trial. The company is also planning to initiate an extension study to provide continued access to atacicept before commercial availability.
Results for: Kidney Disease
A recent study has shed light on the heightened health risks faced by men with diabetes compared to women. The research, conducted by The University of Sydney, Australia, revealed that diabetic men are more prone to complications such as heart disease, leg/foot issues, kidney problems, and eye disorders.
Water fountains mimic your pet’s natural instincts and can actually help prevent disease. One simple purchase can make a world of difference for your pet. The issue at hand? Hydration. It may be time to replace your pet’s water bowl with a fountain.